Dr.Reddy's Laboratories (UK) Limited
Supplier — contracts won
£2.3bnTotal value£2,293,398,973 across every award on file
7Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 7 | £2.3bn |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 28 Oct 2024 | NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | NHS England | Gilead Sciences Limited +12 | £626.5m |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 25 Jun 2025 | NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | NHS England | Roche Products Ltd +27 | £261.9m |
| 30 Sep 2024 | NHS National Framework for Transition products commencing 1 October 2024East Midlands | NHS England | Thornton and Ross Ltd +11 | £16.2m |
| 16 Apr 2025 | NHS National Framework - Generics Housekeeping/Supply Chain Resilience ProductsEast Midlands | NHS England | Drugsrus Ltd +30 | £11.7m |
| 14 Jan 2025 | CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025East Midlands | NHS England | Sun Pharma UK Ltd +5 | £9.9m |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.